SCHEMBL8833175

SCHEMBL8833175

Cc1cc(=S)c2c(O)cc(O)cc2o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.50
CYP3A4 P08684 6/20 0.50
ALDH1A1 P00352 5/20 0.50
HPGD P15428 5/20 0.50
TSHR P16473 4/20 0.50
CA9 Q16790 2/20 0.50
CASP7 P55210 2/20 0.50
CASP1 P29466 1/20 0.50
PIM1 P11309 5/20 0.49
NUAK1 O60285 3/20 0.49
IGF1R P08069 3/20 0.49
SRC P12931 3/20 0.49
KDR P35968 3/20 0.49
PLK1 P53350 3/20 0.49
PKN1 Q16512 3/20 0.49
AURKB Q96GD4 3/20 0.49
ALK Q9UM73 3/20 0.49
GAA P10253 5/20 0.48
MGAM O43451 2/20 0.48
SI P14410 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832745 0.83 PTGS1 (0.68) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL8833077 0.80 ABCB1 (0.50) HSD17B10CYP3A4ALDH1A1HPGDTSHR
Noreugenin SCHEMBL168822 0.78 PTGS2 (0.71) HSD17B10CYP3A4ALDH1A1HPGDTSHR
Noreugenin SCHEMBL29370130 0.78 PTGS2 (0.71) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL29904992 0.75 POLH (0.71) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL7942485 0.73 KMT2A (0.68) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL504349 0.73 MGAM (0.74) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL21671248 0.69 PTGS1 (0.61) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL3782322 0.68 CLK2 (0.63) HSD17B10CYP3A4ALDH1A1HPGDTSHR
SCHEMBL1673012 0.67 PTGS1 (0.62) HSD17B10CYP3A4ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5675023-A VISION DEFECTS; NERVOUS SYSTEM DISORDERS; COMPLICATIONS OF DIABETES TSUMURA & CO. (JP) 1997-10-07 US disclosed
US-5627204-A ENZYME INHIBITORS FOR TREATMENT OF DIABETES TSUMURA & COMPANY (JP) 1997-05-06 US disclosed
US-5521216-A TREATING COMPLICATIONS OF DIABETES TSUMURA & CO. (JP) 1996-05-28 US disclosed
US-5455267-A For reducing side effects of diabetes TSUMURA & CO. (JP) 1995-10-03 US disclosed
EP-0605728-A1 CHROMONE DERIVATIVE AND ALDOSE REDUCTASE INHIBITOR CONTAINING THE SAME AS ACTIVE INGREDIENT TSUMURA & CO. (JP) 1994-07-13 EP disclosed